跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
WYNZORA 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g cream tube - TGA Drug Approval Details
Approvals
/
TGA
/
WYNZORA 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g cream tube
Approved
STANDARD
WYNZORA 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g cream tube
MC2 Therapeutics Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
e6f7970bd883c3e9
Company
MC2 Therapeutics Pty Ltd
Type
Standard
Approval Details
Approval Id
e6f7970bd883c3e9
Product Name
WYNZORA 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g cream tube
Artg Id
427184
Artg Name
WYNZORA 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g cream tube
Sponsor
MC2 Therapeutics Pty Ltd
Artg Date
2024-11-25
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
e6f7970bd883c3e9
Type
Standard
Back to TGA Approvals